Free Trial

Victory Capital Management Inc. Acquires 366,708 Shares of Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background

Victory Capital Management Inc. lifted its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 17.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,475,066 shares of the company's stock after acquiring an additional 366,708 shares during the period. Victory Capital Management Inc. owned approximately 0.30% of Colgate-Palmolive worth $256,937,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in CL. Envestnet Portfolio Solutions Inc. grew its stake in shares of Colgate-Palmolive by 30.1% during the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 24,251 shares of the company's stock worth $2,184,000 after acquiring an additional 5,614 shares in the last quarter. Atomi Financial Group Inc. grew its position in Colgate-Palmolive by 34.7% in the first quarter. Atomi Financial Group Inc. now owns 4,515 shares of the company's stock valued at $407,000 after purchasing an additional 1,162 shares in the last quarter. QRG Capital Management Inc. grew its position in Colgate-Palmolive by 10.5% in the first quarter. QRG Capital Management Inc. now owns 51,524 shares of the company's stock valued at $4,640,000 after purchasing an additional 4,891 shares in the last quarter. Bleakley Financial Group LLC grew its position in Colgate-Palmolive by 3.8% in the first quarter. Bleakley Financial Group LLC now owns 20,832 shares of the company's stock valued at $1,876,000 after purchasing an additional 767 shares in the last quarter. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its holdings in shares of Colgate-Palmolive by 80.3% in the 1st quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,382,089 shares of the company's stock valued at $124,457,000 after acquiring an additional 615,645 shares in the last quarter. Institutional investors own 80.41% of the company's stock.

Insiders Place Their Bets

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the business's stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company's stock, valued at approximately $1,220,874.30. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Stanley J. Sutula III sold 45,410 shares of the company's stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company's stock, valued at $3,456,283.86. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.34% of the company's stock.

Colgate-Palmolive Trading Down 0.5 %

Colgate-Palmolive stock traded down $0.45 during trading hours on Tuesday, hitting $91.51. The stock had a trading volume of 4,927,123 shares, compared to its average volume of 4,377,176. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The stock has a market cap of $74.76 billion, a price-to-earnings ratio of 26.36, a P/E/G ratio of 3.31 and a beta of 0.42. Colgate-Palmolive has a one year low of $75.17 and a one year high of $109.30. The business's 50 day simple moving average is $100.62 and its 200-day simple moving average is $98.52.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.19%. Colgate-Palmolive's dividend payout ratio (DPR) is 57.31%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on CL shares. Morgan Stanley raised their price objective on Colgate-Palmolive from $103.00 to $111.00 and gave the company an "overweight" rating in a report on Monday, July 29th. Jefferies Financial Group downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating and reduced their target price for the stock from $103.00 to $95.00 in a research note on Wednesday, July 24th. Piper Sandler initiated coverage on Colgate-Palmolive in a report on Tuesday, September 24th. They set an "overweight" rating and a $121.00 price objective for the company. Redburn Atlantic raised shares of Colgate-Palmolive to a "hold" rating in a report on Thursday, August 1st. Finally, Evercore ISI boosted their price target on Colgate-Palmolive from $100.00 to $106.00 and gave the company an "outperform" rating in a research note on Thursday, July 18th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $105.11.

Check Out Our Latest Analysis on Colgate-Palmolive

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should you invest $1,000 in Colgate-Palmolive right now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines